Toronto, Canada
March 13, 2002

A Canadian company may have found the ideal solution to environmental concerns about genetically modified field crops.

BioSecure Crops Inc. of Toronto, recently acquired by FuzzyLogic Software Corp. (NASDAQ OTCBB: FZZY), announced today that it has been contracted by MPB Cologne GmbH to test the feasibility of growing potato mini-tubers containing pharmaceutical proteins (Industrial Tubers(TM)) in contained-environment grow chambers.

A series of contained-environment grow chambers will be constructed using the proprietary GroWmax(TM) technology to establish production of mini-tubers supplied by MPB Cologne. Upon completion of the nine-month feasibility study, BioSecure will construct a production scale facility. The location of the facility has not been finalized.

BioSecure Crops will assist MPB Cologne to address the worldwide shortage of antibody manufacturing capacity created by the successful entry into the market of therapeutic antibodies. The worldwide therapeutic antibody market is expected to grow from $3-billion U.S. in 2001 to $24-billion U.S. by 2010.

BioSecure Crops utilizes proprietary technologies to create fully contained growing environments that maximize the output of plant biomass and allow for completely controlled plant production. Plant growing environments can be easily scaled from research to commercial-sized production and can be built anywhere regardless of location or season.

"I am very optimistic that the GroWmax(TM) technology will prove to be the best fit for MPB Cologne's focus on biological safety in plant-made pharmaceuticals," said Klaus During, President and CEO of MPB Cologne. "It allows for maximum flexibility and promises the highest efficiency in production of Industrial Tubers(TM). Exclusive access to the GroWmax(TM) technology for the growing of mini-tubers strengthens the competitive position of both companies."

"We feel that MPB's Industrial Tuber(TM) fits well with BioSecure's technology and will prove to be an excellent platform for the commercial-scale production of a wide range of recombinant proteins," said Doug Coyle, President, BioSecure Crops Inc. "In our assessment, MPB-Cologne's work to date developing the Industrial Tuber(TM) places it in a leadership position in the industry."

MPB Cologne GmbH manufactures new proteins in Industrial Tubers(TM) by using the potato as a plant bioreactor for economical large-scale production. Customers from pharmaceutical, biotechnological and chemical industries will benefit from the comprehensive gene to protein approach of MPB Cologne. MPB has successfully proved the functional equivalence of a scFv antibody produced in Industrial Tubers(TM) in neurite outgrowth from cultured neurons. Upon completion of its first pilot scale productions by mid 2002, purified scFv antibodies will be available in quantities of several tens of grams.

BioSecure Crops is a biotechnology infrastructure company serving the rapidly growing plant-based recombinant protein-manufacturing sector. BioSecure uses proprietary GroWmax(TM) plant growing technology to economically maximize biomass production in fully contained environments. Plants can produce a wide range of high value proteins such as antibodies and enzymes which can be used as vaccines or for a variety of diagnostic and therapeutic purposes.